Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2026-01-21 @ 6:53 AM
Study NCT ID:
NCT02837757
Status:
TERMINATED
Last Update Posted:
2022-05-16
First Post:
2016-07-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Everolimus Modulation of Anti-tumor T CD4 Immune Responses
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
API/2014/48
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None